DE ANDREA, Marco
 Distribuzione geografica
Continente #
NA - Nord America 9.560
EU - Europa 6.116
AS - Asia 3.323
AF - Africa 198
SA - Sud America 129
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.410
Nazione #
US - Stati Uniti d'America 9.386
IT - Italia 1.846
CN - Cina 1.497
IE - Irlanda 744
SE - Svezia 677
SG - Singapore 619
DE - Germania 534
FR - Francia 426
GB - Regno Unito 372
FI - Finlandia 332
UA - Ucraina 282
KR - Corea 276
AT - Austria 258
VN - Vietnam 176
PL - Polonia 173
JP - Giappone 166
IN - India 136
SN - Senegal 129
CA - Canada 126
ID - Indonesia 124
NL - Olanda 96
DK - Danimarca 94
HK - Hong Kong 85
BE - Belgio 76
AU - Australia 72
BR - Brasile 54
TW - Taiwan 48
ES - Italia 42
MX - Messico 42
TR - Turchia 39
GR - Grecia 30
IR - Iran 27
SA - Arabia Saudita 27
RU - Federazione Russa 25
IQ - Iraq 23
PE - Perù 23
RO - Romania 22
IL - Israele 21
PK - Pakistan 20
ZA - Sudafrica 20
CH - Svizzera 19
CZ - Repubblica Ceca 15
NO - Norvegia 14
UG - Uganda 14
EC - Ecuador 13
HR - Croazia 11
PH - Filippine 11
AR - Argentina 10
CO - Colombia 10
CL - Cile 9
EG - Egitto 9
NZ - Nuova Zelanda 9
MY - Malesia 7
PT - Portogallo 6
BO - Bolivia 5
EE - Estonia 5
NG - Nigeria 4
PR - Porto Rico 4
QA - Qatar 4
RS - Serbia 4
SC - Seychelles 4
TH - Thailandia 4
EU - Europa 3
JO - Giordania 3
MA - Marocco 3
MU - Mauritius 3
PY - Paraguay 3
TN - Tunisia 3
BD - Bangladesh 2
BG - Bulgaria 2
ET - Etiopia 2
GH - Ghana 2
HU - Ungheria 2
KE - Kenya 2
LU - Lussemburgo 2
SI - Slovenia 2
ZM - Zambia 2
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
IS - Islanda 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
ME - Montenegro 1
NI - Nicaragua 1
NP - Nepal 1
SM - San Marino 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
YE - Yemen 1
Totale 19.410
Città #
Chandler 1.532
Houston 748
Dublin 733
Beijing 625
Fairfield 571
Singapore 489
Ann Arbor 427
Torino 384
Ashburn 326
Woodbridge 319
Villeurbanne 257
Jacksonville 242
Vienna 241
Wilmington 240
Seattle 223
Pisa 207
Cambridge 192
Princeton 189
Medford 188
Dearborn 175
Nyköping 175
Redwood City 152
Warsaw 152
Dong Ket 135
Turin 124
Jakarta 121
Sovicille 115
Guangzhou 104
Boston 94
Shanghai 93
Fremont 90
New York 90
Milan 83
Rome 67
Santa Clara 64
Nanjing 63
Boardman 62
Piemonte 48
Toronto 46
Los Angeles 45
Brussels 39
Hangzhou 38
Baltimore 37
San Diego 37
Lappeenranta 36
Tokyo 36
Helsinki 35
Taipei 34
Seongnam 32
Washington 32
Phoenix 30
Norwalk 29
Novara 28
Chicago 27
London 27
Verona 26
Higashiayase 25
Kunming 25
Philadelphia 25
Silver Spring 25
Hefei 24
New Delhi 24
Maddaloni 23
Munich 23
Seoul 23
Shenyang 22
Hebei 21
Paris 21
Pittsburgh 21
Wuhan 21
Jinan 20
Ottawa 19
Berlin 17
Frankfurt am Main 17
Galveston 17
Jeddah 17
Melbourne 17
San Mauro Torinese 17
Utrecht 17
Orange 16
Chengdu 15
Des Moines 15
Elk Grove Village 15
Falls Church 15
Florence 15
Gongju 15
Ningbo 15
Vercelli 15
Zhengzhou 15
Central 14
Madison 14
Madrid 14
San Mateo 14
Buffalo 13
Cardiff 13
Chongqing 13
Padova 13
Sulaymaniyah 13
Changsha 12
Erlangen 12
Totale 11.531
Nome #
Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy 432
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 368
Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease 341
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 318
Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders 312
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells 296
α- and β-Papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions 279
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 271
Identification of the skin virome in a young boy with widespread HPV2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine. 258
Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. 247
The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation 247
Mislocalization of the interferon inducible protein IFI16 by environmental insults: Implications in autoimmunity 247
Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. 239
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 235
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 234
Melusin is a new muscle-specific interactor for beta(1) integrin cytoplasmic domain. 229
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 221
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. M. DE ANDREA CO-FIRST AUTHOR 211
Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients 208
Analysis of human β-papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of patients with chronic lymphocytic leukaemia 194
In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16. M. DE ANDREA CO-FIRST AUTHOR 180
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 179
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 178
Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index 178
The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response 174
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 172
The US16 gene of human cytomegalovirus is equired for efficient viral infection of endothelial and epithelial cells.[Bronzini M.*, Luganini A.* co-first author] 171
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 167
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16 165
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 164
HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling. 164
The intracellular DNA Sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication [*Gariano GR, *Dell'Oste V*, co-first authors] 161
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters. M. DE ANDREA CO-FIRST AUTHOR 160
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 159
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 158
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 147
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer 145
Restriction factors against human CMV 144
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 140
The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes 137
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters 133
HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion 131
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 131
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 131
Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis 130
Strigolactone analogs are promising antiviral agents against Herpesviruses 129
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 127
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 126
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 121
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 121
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 121
Lack of EVER2 Protein in Two Epidermodysplasia Verruciformis Patients with Skin Cancer Presenting Previously Unreported Homozygous Genetic Deletions in the EVER2 Gene 119
Interferon α/β 119
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 118
The interferon-inducibel IFI16 gene is a restriction factor for Human cytomegalovirus replication 117
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 116
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus 114
IFI16 expression is related to selected transcription factors during B-cell differentiation 112
The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. 109
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) 108
Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice 108
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 107
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 105
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 105
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 103
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 100
HPV E7 Oncoprotein Subverts Host Innate Immunity Via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes 100
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 100
Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression 99
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 99
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 97
β-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort 97
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 96
The antiproliferative activity of the murine interferon-inducible Ifi 200 proteins depends on the presence of two 200 amino acid domains. 95
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 89
The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Cytomegalovirus Replication 89
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 88
Bifunctional role of interferon inducible IFI16 protein inside and outside of endothelial cells 88
A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity 88
The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication 88
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 88
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 87
High beta-HPV DNA Loads and Strong Seroreactivity Are Present in Epidermodysplasia Verruciformis 86
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 86
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 86
The Mouse Interferon-Inducible Gene Ifi204 Product Interacts with the Tpr Protein, a Component of the Nuclear Pore Complex 85
Tuning the Orchestra: HCMV vs. Innate Immunity. 85
Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis 84
The interferon-inducible 204 gene is transcriptionally activated by mouse cytomegalovirus and is required for its replication. M. DE ANDREA CO-FIRST AUTHOR 84
Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models 84
Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma-derived cell lines 83
Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. 82
Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells 81
P600 Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD 81
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. [*Azzimonti B, *Dell'Oste V, co-first authors] 81
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 80
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 79
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 78
The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase 78
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 78
Totale 14.660
Categoria #
all - tutte 53.374
article - articoli 0
book - libri 0
conference - conferenze 20.747
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.563 0 0 0 316 225 713 316 189 257 218 160 169
2020/20212.307 195 125 142 186 230 160 217 139 229 222 147 315
2021/20222.320 103 128 143 234 104 92 129 136 87 168 569 427
2022/20234.268 262 207 87 455 477 1.005 235 353 678 123 202 184
2023/20242.100 264 296 145 132 174 258 100 130 30 156 163 252
2024/20251.099 146 490 370 93 0 0 0 0 0 0 0 0
Totale 20.033